Richard Barth
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
T-Lymphocytes | 9 | 1985 | 182 |
Why?
| Bleomycin | 5 | 1993 | 28 |
Why?
| Pulmonary Fibrosis | 4 | 1993 | 48 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1988 | 18 |
Why?
| Antigens, CD80 | 5 | 1994 | 19 |
Why?
| Muramidase | 3 | 1997 | 18 |
Why?
| Keratinocytes | 4 | 1994 | 36 |
Why?
| Mice, Transgenic | 15 | 1994 | 209 |
Why?
| Mice | 30 | 1982 | 623 |
Why?
| Peptide Fragments | 3 | 1997 | 144 |
Why?
| Antigens, CD | 8 | 1993 | 128 |
Why?
| Lung | 3 | 1997 | 232 |
Why?
| Chromosome Mapping | 3 | 1982 | 107 |
Why?
| Epitopes | 5 | 1985 | 86 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2000 | 17 |
Why?
| Mice, Inbred C57BL | 13 | 1982 | 318 |
Why?
| Genetic Predisposition to Disease | 1 | 2002 | 131 |
Why?
| Sialoglycoproteins | 5 | 1993 | 31 |
Why?
| T-Lymphocyte Subsets | 1 | 2000 | 70 |
Why?
| Animals | 30 | 1982 | 1031 |
Why?
| Isoantigens | 1 | 1997 | 18 |
Why?
| Prostate-Specific Antigen | 4 | 1996 | 34 |
Why?
| Mice, Inbred DBA | 8 | 1982 | 38 |
Why?
| Skin | 1 | 1998 | 177 |
Why?
| Receptors, Antigen, T-Cell | 4 | 1985 | 34 |
Why?
| Cytokines | 2 | 1993 | 207 |
Why?
| Haptens | 2 | 1998 | 10 |
Why?
| Molecular Sequence Data | 6 | 1988 | 404 |
Why?
| Dermatitis, Contact | 2 | 1998 | 9 |
Why?
| B-Lymphocytes | 4 | 1995 | 134 |
Why?
| Amino Acid Sequence | 5 | 1985 | 319 |
Why?
| Antigens, T-Independent | 2 | 1997 | 5 |
Why?
| Mice, Inbred BALB C | 7 | 1982 | 176 |
Why?
| Immunologic Deficiency Syndromes | 2 | 1996 | 30 |
Why?
| Gene Expression | 6 | 1996 | 291 |
Why?
| Immune Tolerance | 4 | 1994 | 72 |
Why?
| Base Sequence | 4 | 1993 | 371 |
Why?
| Lymphocyte Activation | 4 | 1996 | 137 |
Why?
| Uteroglobin | 2 | 1997 | 12 |
Why?
| Th1 Cells | 2 | 1998 | 33 |
Why?
| Genetic Linkage | 3 | 1982 | 57 |
Why?
| DNA Primers | 3 | 1993 | 208 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2005 | 6 |
Why?
| Antigens | 1 | 2005 | 66 |
Why?
| Lung Injury | 1 | 2005 | 36 |
Why?
| Polymerase Chain Reaction | 3 | 1993 | 279 |
Why?
| Chickens | 1 | 2005 | 81 |
Why?
| Immunoglobulin E | 1 | 2005 | 28 |
Why?
| Genes | 4 | 1982 | 82 |
Why?
| RNA, Messenger | 6 | 1982 | 394 |
Why?
| Immunoglobulin Class Switching | 1 | 2004 | 17 |
Why?
| Antigen-Presenting Cells | 3 | 1996 | 40 |
Why?
| Spleen | 4 | 1995 | 129 |
Why?
| Pseudomonas aeruginosa | 1 | 2006 | 33 |
Why?
| B-Lymphocyte Subsets | 1 | 2004 | 33 |
Why?
| Quantitative Trait, Heritable | 1 | 2002 | 2 |
Why?
| Fibroblast Growth Factors | 1 | 2002 | 26 |
Why?
| Cell Division | 3 | 1997 | 273 |
Why?
| Mice, Inbred Strains | 3 | 1982 | 118 |
Why?
| Genetic Markers | 1 | 2002 | 78 |
Why?
| Transcription, Genetic | 3 | 1984 | 253 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 1997 | 43 |
Why?
| Immunodominant Epitopes | 1 | 2000 | 14 |
Why?
| Antigens, CD43 | 5 | 1993 | 9 |
Why?
| Membrane Glycoproteins | 2 | 1998 | 154 |
Why?
| Immunoglobulin G | 2 | 1997 | 191 |
Why?
| Candidiasis, Cutaneous | 1 | 1998 | 3 |
Why?
| Tissue Kallikreins | 1 | 1998 | 7 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1999 | 38 |
Why?
| Hypersensitivity, Delayed | 2 | 1994 | 35 |
Why?
| Thymus Gland | 1 | 1999 | 57 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 1998 | 113 |
Why?
| Gene Expression Regulation | 3 | 1982 | 277 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1998 | 3 |
Why?
| Pulmonary Surfactants | 2 | 1997 | 35 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1998 | 10 |
Why?
| Species Specificity | 3 | 1988 | 186 |
Why?
| Liver | 2 | 1982 | 248 |
Why?
| DNA Probes | 1 | 1998 | 61 |
Why?
| H-2 Antigens | 1 | 1997 | 12 |
Why?
| Inflammation Mediators | 1 | 1998 | 56 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 210 |
Why?
| DNA, Complementary | 1 | 1998 | 139 |
Why?
| Tumor Cells, Cultured | 2 | 1996 | 233 |
Why?
| Proteolipids | 1 | 1997 | 20 |
Why?
| Antibiotics, Antineoplastic | 1 | 1997 | 35 |
Why?
| Cytochrome c Group | 1 | 1997 | 20 |
Why?
| Signal Transduction | 1 | 2006 | 313 |
Why?
| Proteins | 4 | 1982 | 192 |
Why?
| Immunologic Memory | 1 | 1997 | 51 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 91 |
Why?
| Male | 9 | 1993 | 1553 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 52 |
Why?
| Neoplasms, Experimental | 1 | 1996 | 72 |
Why?
| Protein Biosynthesis | 1 | 1997 | 113 |
Why?
| Immunoconjugates | 1 | 1994 | 11 |
Why?
| Prostatic Neoplasms | 2 | 1996 | 120 |
Why?
| Kinetics | 1 | 1998 | 349 |
Why?
| Enzyme Inhibitors | 1 | 1997 | 216 |
Why?
| Inflammation | 1 | 1998 | 208 |
Why?
| Antigens, CD86 | 2 | 1998 | 7 |
Why?
| Enhancer Elements, Genetic | 3 | 1995 | 43 |
Why?
| Hematopoietic Stem Cells | 1 | 1995 | 69 |
Why?
| Polymorphism, Genetic | 3 | 1982 | 94 |
Why?
| Epithelial Cells | 3 | 1997 | 135 |
Why?
| Antibody Formation | 2 | 1997 | 89 |
Why?
| Interferon-gamma | 2 | 1998 | 133 |
Why?
| Female | 5 | 1993 | 1643 |
Why?
| Muridae | 1 | 1989 | 11 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1989 | 32 |
Why?
| Macromolecular Substances | 2 | 1985 | 92 |
Why?
| Hemocyanin | 2 | 1996 | 16 |
Why?
| Epithelium | 2 | 1997 | 101 |
Why?
| Transfection | 3 | 1993 | 237 |
Why?
| Cell Differentiation | 3 | 1982 | 262 |
Why?
| Lymphocyte Cooperation | 2 | 1996 | 12 |
Why?
| Immunotherapy | 2 | 1997 | 48 |
Why?
| Recombination, Genetic | 2 | 1982 | 78 |
Why?
| Cell Line | 4 | 1984 | 375 |
Why?
| Models, Biological | 2 | 1996 | 410 |
Why?
| Porins | 1 | 2006 | 11 |
Why?
| Regulon | 1 | 2006 | 9 |
Why?
| Age Factors | 2 | 1982 | 480 |
Why?
| Serpins | 1 | 1985 | 14 |
Why?
| Lipopolysaccharides | 2 | 1996 | 98 |
Why?
| Evolution, Molecular | 1 | 2006 | 45 |
Why?
| Major Histocompatibility Complex | 1 | 1985 | 23 |
Why?
| Genes, Regulator | 1 | 1985 | 20 |
Why?
| Protease Inhibitors | 1 | 1985 | 39 |
Why?
| Dinitrofluorobenzene | 1 | 2005 | 5 |
Why?
| Chlorobenzenes | 1 | 2005 | 3 |
Why?
| Ear Diseases | 1 | 2005 | 8 |
Why?
| Virulence Factors | 1 | 2006 | 24 |
Why?
| Immunologic Factors | 1 | 2006 | 46 |
Why?
| Nucleic Acid Hybridization | 2 | 1982 | 94 |
Why?
| Mice, Inbred SENCAR | 1 | 2004 | 3 |
Why?
| Oncogenes | 1 | 1984 | 24 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2006 | 26 |
Why?
| Osteosarcoma | 1 | 1984 | 31 |
Why?
| Models, Immunological | 1 | 2004 | 40 |
Why?
| Platelet-Derived Growth Factor | 1 | 1984 | 37 |
Why?
| Edema | 1 | 2005 | 67 |
Why?
| Recombinant Fusion Proteins | 2 | 1995 | 189 |
Why?
| Up-Regulation | 1 | 2006 | 183 |
Why?
| Neoplasm Proteins | 1 | 1984 | 110 |
Why?
| Translocation, Genetic | 1 | 1982 | 35 |
Why?
| Disease Models, Animal | 1 | 2004 | 349 |
Why?
| Humans | 7 | 1984 | 1856 |
Why?
| Antigens, CD28 | 1 | 1999 | 25 |
Why?
| Mutation | 1 | 1985 | 340 |
Why?
| Molecular Weight | 2 | 1984 | 154 |
Why?
| Antibodies, Fungal | 1 | 1998 | 7 |
Why?
| Transgenes | 1 | 1998 | 56 |
Why?
| Antigens, Fungal | 1 | 1998 | 11 |
Why?
| Epidermis | 1 | 1998 | 30 |
Why?
| Models, Genetic | 1 | 1998 | 90 |
Why?
| Ficoll | 1 | 1997 | 4 |
Why?
| Down-Regulation | 1 | 1999 | 150 |
Why?
| Peritoneal Cavity | 1 | 1997 | 28 |
Why?
| Genitalia, Male | 1 | 1997 | 12 |
Why?
| Genes, Immunoglobulin | 1 | 1997 | 28 |
Why?
| Cells, Cultured | 1 | 2004 | 447 |
Why?
| Radiation Chimera | 1 | 1997 | 11 |
Why?
| Restriction Mapping | 1 | 1997 | 74 |
Why?
| Interphase | 1 | 1997 | 26 |
Why?
| Leukocytes | 1 | 1998 | 94 |
Why?
| Immunosuppression | 1 | 1997 | 47 |
Why?
| Protein Engineering | 1 | 1997 | 14 |
Why?
| Candida albicans | 1 | 1998 | 37 |
Why?
| Organ Specificity | 1 | 1997 | 104 |
Why?
| Cytotoxicity, Immunologic | 1 | 1997 | 54 |
Why?
| Ovalbumin | 1 | 1996 | 32 |
Why?
| Immunoglobulins | 1 | 1996 | 54 |
Why?
| Mast-Cell Sarcoma | 1 | 1996 | 9 |
Why?
| Lymph Nodes | 1 | 1998 | 106 |
Why?
| Lymphoid Tissue | 1 | 1997 | 34 |
Why?
| Immunoglobulin M | 1 | 1996 | 81 |
Why?
| DNA Restriction Enzymes | 2 | 1985 | 44 |
Why?
| Immunity, Cellular | 1 | 1997 | 85 |
Why?
| Prostate | 1 | 1998 | 55 |
Why?
| Intubation, Intratracheal | 1 | 1997 | 50 |
Why?
| In Situ Hybridization | 1 | 1997 | 135 |
Why?
| Immunization | 1 | 1997 | 85 |
Why?
| Cell Adhesion | 1 | 1996 | 113 |
Why?
| Bone Marrow | 1 | 1997 | 109 |
Why?
| CTLA-4 Antigen | 1 | 1994 | 10 |
Why?
| Gene Therapy | 1 | 1997 | 89 |
Why?
| Immunohistochemistry | 1 | 1998 | 355 |
Why?
| Antigens, Differentiation | 1 | 1994 | 53 |
Why?
| Recombinant Proteins | 1 | 1997 | 290 |
Why?
| Cell Count | 1 | 1995 | 163 |
Why?
| Biological Markers | 1 | 1997 | 262 |
Why?
| Mice, Inbred C3H | 1 | 1994 | 86 |
Why?
| Cell Survival | 1 | 1995 | 229 |
Why?
| Lung Neoplasms | 1 | 1996 | 159 |
Why?
| Immunoblotting | 1 | 1993 | 119 |
Why?
| Flow Cytometry | 1 | 1995 | 216 |
Why?
| Fetus | 1 | 1993 | 105 |
Why?
| RNA | 2 | 1984 | 126 |
Why?
| Animals, Wild | 1 | 1989 | 6 |
Why?
| Haplotypes | 1 | 1989 | 28 |
Why?
| Multigene Family | 1 | 1989 | 52 |
Why?
| Apoptosis | 1 | 1995 | 265 |
Why?
| Antibodies, Monoclonal | 1 | 1993 | 241 |
Why?
| Pregnancy | 1 | 1993 | 455 |
Why?
| Chromosome Deletion | 1 | 1987 | 46 |
Why?
| Clone Cells | 1 | 1987 | 92 |
Why?
| Trypsin Inhibitors | 1 | 1985 | 4 |
Why?
| Rats, Inbred BUF | 1 | 1985 | 5 |
Why?
| Hypophysectomy | 1 | 1985 | 11 |
Why?
| alpha 1-Antitrypsin | 1 | 1985 | 14 |
Why?
| Blood Proteins | 1 | 1985 | 71 |
Why?
| Poly A | 1 | 1984 | 16 |
Why?
| DNA Replication | 1 | 1984 | 75 |
Why?
| Mice, Inbred AKR | 1 | 1982 | 7 |
Why?
| Proteinuria | 1 | 1982 | 20 |
Why?
| Rats | 1 | 1985 | 530 |
Why?
| DNA | 1 | 1982 | 262 |
Why?
|
|
Barth's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
